Sulindac: all 24 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal CancerTerminatedNCT01856322Phase 2Results posted
- NSAID Effects on Clinical and Imaging Breast BiomarkersCompletedNCT01761877Phase 2Results posted
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)CompletedNCT01483144Phase 3Results posted
- A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsCompletedNCT01187901Phase 2Results posted
- Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of MelanomaCompletedNCT00841204Phase 2Results posted
- Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00392665Phase 2Results posted
- Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaCompletedNCT00368927Phase 2Results posted
- Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal NeoplasiaCompletedNCT00335504Phase 2Results posted
- A Randomized Study of Sulindac in Oral Premalignant LesionsCompletedNCT00299195Not applicableResults posted
- Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon PolypsCompletedNCT00118365Phase 3Results posted
- Sulindac and Tamoxifen in Treating Patients With Desmoid TumorCompletedNCT00068419Phase 2Results posted
- The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)Active, not recruitingNCT04207944Phase 2
- Sulindac for Patients With AMLWithdrawnNCT01843179Phase 2
- Urinary Biomarker Study With Sulindac and DifluoromethylornithineWithdrawnNCT01636128Phase 2
- Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01515137Phase 1
- S0820, Adenoma and Second Primary Prevention TrialActive, not recruitingNCT01349881Phase 3
- A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)WithdrawnNCT01245816Phase 3
- Sulindac and Epirubicin in Treating Patients With Metastatic Malignant MelanomaCompletedNCT00755976Phase 2
- Sulindac Capsules Compared With Sulindac Tablets in Healthy VolunteersCompletedNCT00343629Not applicable
- Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous PolyposisStatus unknownNCT00319007Phase 2
- Sulindac in Preventing Breast Cancer in Women at High Risk for Breast CancerCompletedNCT00245024Phase 1
- Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal CancerTerminatedNCT00062023Phase 2
- Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedNCT00039520Phase 2
- Sulindac and Plant Compounds in Preventing Colon CancerTerminatedNCT00003365Not applicable